India to United States: Heparin Export Trade Route
India has recorded 885 verified shipments of Heparin exported to United States, representing a combined trade value of $125.7M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $142.1K USD. The leading Indian exporter is GLAND PHARMA LTD, which accounts for 49% of total export value with 588 shipments worth $61.7M USD. On the buying side, FRESENIUS KABI USA, LLC is the largest importer in United States with $36.4M USD in purchases. The top 3 suppliers — GLAND PHARMA LTD, GLAND PHARMA LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Heparin corridor is one of India's established pharmaceutical export routes, with 885 shipments documented worth a combined $125.7M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's heparin manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $142.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with heparin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 26.4%, placing it at rank #18 among India's top heparin export destinations globally.
On the import side, key buyers of Indian heparin in United States include FRESENIUS KABI USA, LLC, EVERSANA, HOSPIRA INC and 20 others. FRESENIUS KABI USA, LLC is the single largest importer with 345 shipments valued at $36.4M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ3
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#18
- Annual growth+26.4%
- Demand growth+24.1%
- Regulatory ease83/100
Top 10 Indian Heparin Exporters to United States
Showing top 10 of 11 Indian suppliers exporting Heparin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLAND PHARMA LTD Avg $104.9K per shipment | 588 | $61.7M | 49.1% |
| 2 | GLAND PHARMA LIMITED Avg $164.7K per shipment | 169 | $27.8M | 22.1% |
| 3 | PFIZER HEALTHCARE INDIA PRIVATE LIMITED Avg $826.2K per shipment | 31 | $25.6M | 20.4% |
| 4 | MYLAN LABORATORIES LIMITED Avg $157.3K per shipment | 58 | $9.1M | 7.3% |
| 5 | BIOLOGICAL E. LIMITED Avg $223.6K per shipment | 4 | $894.3K | 0.7% |
| 6 | BIOLOGICAL E LIMITED Avg $156.0K per shipment | 3 | $468.1K | 0.4% |
| 7 | ATLAS ENTERPRISES Avg $4.9K per shipment | 23 | $111.8K | 0.1% |
| 8 | KALINDI OVERSEAS Avg $360 per shipment | 3 | $1.1K | 0.0% |
| 9 | PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT Avg $12 per shipment | 4 | $48 | 0.0% |
| 10 | HCG MANAVATA ONCOLOGY LLP Avg $34 per shipment | 1 | $34 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting heparin to United States, ranked by total trade value. The listed exporters are: GLAND PHARMA LTD, GLAND PHARMA LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, BIOLOGICAL E. LIMITED, BIOLOGICAL E LIMITED, ATLAS ENTERPRISES, KALINDI OVERSEAS, PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT, HCG MANAVATA ONCOLOGY LLP. GLAND PHARMA LTD is the dominant supplier with 588 shipments worth $61.7M USD, giving it a 49% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to United States Heparin export route.
Top 10 Heparin Importers in United States
Showing top 10 of 23 known buyers in United States receiving Heparin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian heparin in United States include FRESENIUS KABI USA, LLC, EVERSANA, HOSPIRA INC, FRESENIUS KABI USA LLC, XXSPIXX INX, among 23 total buyers. The largest importer is FRESENIUS KABI USA, LLC, accounting for $36.4M USD across 345 shipments — representing 29% of all heparin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI USA, LLC | 345 | $36.4M | 28.9% |
| 2 | EVERSANA | 261 | $26.9M | 21.4% |
| 3 | HOSPIRA INC | 19 | $16.3M | 13.0% |
| 4 | FRESENIUS KABI USA LLC | 69 | $11.8M | 9.4% |
| 5 | XXSPIXX INX | 12 | $9.3M | 7.4% |
| 6 | MYLAN INSTITUTIONAL INC 2898 | 50 | $8.0M | 6.4% |
| 7 | EVERSANA EVERSANA | 44 | $7.4M | 5.9% |
| 8 | EVERSANA LIFE SCIENCE SERVICES LLC | 38 | $7.1M | 5.6% |
| 9 | BE PHARMACEUTICALS INC | 7 | $1.4M | 1.1% |
| 10 | MYLAN INSTITUTIONAL INC | 8 | $1.1M | 0.9% |
Showing top 10 of 23 Heparin importers in United States on this route.
Top 10 Heparin Formulations Imported by United States
Showing top 10 of 175 product formulations shipped on the India to United States Heparin route, ranked by trade value
United States imports a wide range of heparin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — HEPARIN 30000U/30ML SSOL 1X25 MDV — accounts for $20.6M USD across 27 shipments. There are 175 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HEPARIN 30000U/30ML SSOL 1X25 MDV | 27 | $20.6M | 16.4% |
| 2 | LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PREFILLED SYRINGE | 147 | $13.4M | 10.7% |
| 3 | LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0 4ML PREFILLED SYRINGE | 31 | $5.6M | 4.5% |
| 4 | HEPARIN 5000IU/ML SSOL 25X1ML SDV | 3 | $4.4M | 3.5% |
| 5 | (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG in 0.4ml PRE-FILLED SYRINGES | 43 | $4.3M | 3.4% |
| 6 | (LOW MOLECULAR WEIGHT HEPARIN) ENOXAPARIN SODIUM INJECTION USP, 40MG PRE-FILLEDSYRINGES | 40 | $3.6M | 2.9% |
| 7 | HEPARIN SODIUM INJECTION USP 5000 USP HEPARIN UNITS/ML 1ML FILL IN 2ML VIAL | 18 | $3.0M | 2.4% |
| 8 | LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 30MG IN 0.3ML PREFILLED SYRINGE | 25 | $2.8M | 2.3% |
| 9 | LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0.4ML PREFILLED SYRINGE | 14 | $2.4M | 1.9% |
| 10 | HEPARIN SODIUM INJECTION USP, 1000 USP HEPARIN UNITS/ML 30ML FILL IN A VIAL | 9 | $2.4M | 1.9% |
Showing top 10 of 175 Heparin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 500 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's heparin exports to United States are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 588 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLAND PHARMA LTD, GLAND PHARMA LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED — together account for 92% of total trade value on this route. The average shipment value of $142.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as low molecular weight heparin enoxaparinsodium injection usp, 40mg in 0.4ml prefilled syringe and low molecular weight heparin enoxaparinsodium injection usp 40mg in 0 4ml prefilled syringe, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FRESENIUS KABI USA, LLC is the largest importer with 345 shipments worth $36.4M USD — representing 29% of all heparin imports from India on this route. A total of 23 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $125.7M
- Avg. Shipment
- $142.1K
- Suppliers
- 11
- Buyers
- 23
- Transit (Sea)
- ~34 days
- Annual Growth
- +26.4%
Reverse Direction
United States → India — Heparin (Import)Other Heparin Routes
Unlock the Full India to United States Heparin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 885 shipments on this route.
Frequently Asked Questions — India to United States Heparin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Heparin to United States?
The leading Indian exporters of Heparin to United States are GLAND PHARMA LTD, GLAND PHARMA LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED. GLAND PHARMA LTD holds the largest market share at approximately 49% of total trade value on this route.
Q What is the total value of Heparin exports from India to United States?
India exports Heparin to United States worth approximately $125.7M USD across 885 recorded shipments. The average value per shipment is $142.1K USD.
Q Which ports does India use to ship Heparin to United States?
The most active port of origin is HYDERABAD ICD with 500 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Heparin?
The average transit time for Heparin shipments from India to United States is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Heparin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 26.4% with demand growth tracking at 24.1%. The route is ranked #18 among India's top Heparin export destinations globally.
Q How many suppliers are active on the India to United States Heparin route?
There are currently 11 active Indian suppliers exporting Heparin to United States. The market is moderately concentrated with GLAND PHARMA LTD accounting for 49% of total shipment value.
Q Who are the main importers of Heparin from India in United States?
The leading importers of Indian Heparin in United States include FRESENIUS KABI USA, LLC, EVERSANA, HOSPIRA INC, FRESENIUS KABI USA LLC, XXSPIXX INX. FRESENIUS KABI USA, LLC is the largest buyer with 345 shipments worth $36.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Heparin.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 23 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 885 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
885 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists